肠道疾病检测市场－全球产业规模、份额、趋势、机会和预测，依疾病类型、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球肠道疾病检测市场规模为41.2亿美元，预计2030年将以4.87%的复合年增长率成长至54.8亿美元。肠道疾病检测涵盖旨在识别影响胃肠道的感染（通常由细菌、病毒或寄生虫引起）的诊断程序。全球肠道感染盛行率的不断上升以及诊断方法的持续进步是推动全球肠道疾病检测市场成长的主要因素。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球肠道疾病检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依疾病类型分类（细菌性肠疾病、病毒性肠疾病、寄生虫性肠疾病、轮状病毒、诺罗病毒）
  • 按最终使用者（医院和诊所、诊断中心、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美肠道疾病检测市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲肠道疾病检测市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区肠道疾病检测市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲肠道疾病检测市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲肠道疾病检测市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球肠道疾病检测市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Abbott Laboratories Ltd.
• Becton Dickinson & Co.
• Biomerica Inc.
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Cepheid
• Coris BioConcept
• DiaSorin SpA
• Meridian Bioscience Inc.
• Quest Diagnostics Incorporated

第十六章：策略建议

第17章调查会社について・免责事项

The Global Enteric Disease Testing Market, valued at USD 4.12 Billion in 2024, is projected to experience a CAGR of 4.87% to reach USD 5.48 Billion by 2030. Enteric disease testing encompasses diagnostic procedures designed to identify infections affecting the gastrointestinal tract, typically caused by bacteria, viruses, or parasites. The global market for these tests is primarily driven by the escalating prevalence of enteric infections worldwide and continuous advancements in diagnostic methodologies.

Key Market Drivers

The increasing global burden of enteric infections significantly fuels the demand for diagnostic testing solutions. The widespread prevalence of these infections, often exacerbated by inadequate sanitation and contaminated food or water, necessitates robust surveillance and rapid identification to manage outbreaks and prevent further spread. For instance, according to the CDC's Foodborne Diseases Active Surveillance Network (FoodNet) 2023 Preliminary Data, the incidence of infections from pathogens such as Campylobacter, Cyclospora, Shiga toxin-producing E. coli (STEC), Vibrio, and Yersinia increased in 2023 compared with the 2016-2018 baseline, underscoring a persistent and growing threat. Concurrently, technological innovations in diagnostic testing are transforming the market by offering more accurate, faster, and accessible detection methods, including molecular diagnostics, immunoassays, and point-of-care platforms.

Key Market Challenges

The elevated costs associated with developing and implementing advanced diagnostic technologies present a significant impediment to the growth of the Global Enteric Disease Testing Market. These high expenditures directly limit the adoption of sophisticated testing platforms, particularly within healthcare systems operating in resource-constrained environments. Such financial barriers restrict access to accurate and rapid diagnostics, leading to delayed diagnoses and treatment for enteric infections. This directly reduces the market penetration of advanced solutions, as facilities are often compelled to prioritize less expensive, albeit potentially less effective, testing methods.

Key Market Trends

Digital health integration within diagnostic workflows is a pivotal trend, streamlining how patient data is collected, shared, and managed. This development connects diagnostic platforms with electronic health records and telehealth systems, enhancing efficiency and accessibility. According to the CDC, in April 2024, over 36,000 healthcare facilities could send electronic case reports, an increase from over 25,000 in early 2023, facilitating quicker public health responses to infectious disease threats. This interconnectivity supports comprehensive patient management and rapid epidemiological surveillance.

Key Market Players

• Abbott Laboratories Ltd.
• Becton Dickinson & Co.
• Biomerica Inc.
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Cepheid
• Coris BioConcept
• DiaSorin S.p.A.
• Meridian Bioscience Inc.
• Quest Diagnostics Incorporated

Report Scope:

In this report, the Global Enteric Disease Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Enteric Disease Testing Market, By Disease Type:

• Bacterial Enteric Diseases
• Viral Enteric Diseases
• Parasitic Enteric Diseases
• Rotavirus
• Norovirus

Enteric Disease Testing Market, By End-User:

• Hospitals & Clinics
• Diagnostic Centers
• Others

Enteric Disease Testing Market, By Region:

• North America
• Europe
• Asia-Pacific
• Soth America
• MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Enteric Disease Testing Market.

Available Customizations:

Global Enteric Disease Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Enteric Disease Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases, Rotavirus, Norovirus)
  • 5.2.2. By End-User (Hospitals & Clinics, Diagnostic Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Enteric Disease Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Type
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Enteric Disease Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Type
      • 6.3.1.2.2. By End-User
  • 6.3.2. Canada Enteric Disease Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Type
      • 6.3.2.2.2. By End-User
  • 6.3.3. Mexico Enteric Disease Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Type
      • 6.3.3.2.2. By End-User

7. Europe Enteric Disease Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Type
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Enteric Disease Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Type
      • 7.3.1.2.2. By End-User
  • 7.3.2. France Enteric Disease Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Type
      • 7.3.2.2.2. By End-User
  • 7.3.3. United Kingdom Enteric Disease Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Disease Type
      • 7.3.3.2.2. By End-User
  • 7.3.4. Italy Enteric Disease Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Type
      • 7.3.4.2.2. By End-User
  • 7.3.5. Spain Enteric Disease Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Type
      • 7.3.5.2.2. By End-User

8. Asia Pacific Enteric Disease Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Type
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Enteric Disease Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Type
      • 8.3.1.2.2. By End-User
  • 8.3.2. India Enteric Disease Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Type
      • 8.3.2.2.2. By End-User
  • 8.3.3. Japan Enteric Disease Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Type
      • 8.3.3.2.2. By End-User
  • 8.3.4. South Korea Enteric Disease Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Type
      • 8.3.4.2.2. By End-User
  • 8.3.5. Australia Enteric Disease Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Type
      • 8.3.5.2.2. By End-User

9. Middle East & Africa Enteric Disease Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Type
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Enteric Disease Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Type
      • 9.3.1.2.2. By End-User
  • 9.3.2. UAE Enteric Disease Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Type
      • 9.3.2.2.2. By End-User
  • 9.3.3. South Africa Enteric Disease Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Type
      • 9.3.3.2.2. By End-User

10. South America Enteric Disease Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Type
  • 10.2.2. By End-User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Enteric Disease Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Type
      • 10.3.1.2.2. By End-User
  • 10.3.2. Colombia Enteric Disease Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Type
      • 10.3.2.2.2. By End-User
  • 10.3.3. Argentina Enteric Disease Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Type
      • 10.3.3.2.2. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Enteric Disease Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton Dickinson & Co.
• 15.3. Biomerica Inc.
• 15.4. BioMerieux SA
• 15.5. Bio-Rad Laboratories, Inc.
• 15.6. Cepheid
• 15.7. Coris BioConcept
• 15.8. DiaSorin S.p.A.
• 15.9. Meridian Bioscience Inc.
• 15.10. Quest Diagnostics Incorporated

16. Strategic Recommendations

17. About Us & Disclaimer